Skip to main content

Table 3 Switching proportion and patterns from initial therapy within 6 months, stratified by initial antipsychotic prescribed

From: Low continuation of antipsychotic therapy in Parkinson disease – intolerance, ineffectiveness, or inertia?

Initial Agent

Switched, n (row%)

Switching to drug, n (row %)

P

Q

A

R

O

Other antipsychotic

Pimavanserin (n = 153)

12 (7.8)

11 (91.7)

0 (0)

0 (0)

0 (0)

1 (8.3)

Quetiapine (n = 2452)

120 (4.9)

32 (26.7)

6 (5.0)

34 (28.3)

24 (20.0)

24 (20.0)

Aripiprazole

(n = 169)

8 (4.7)

0 (0)

6 (75.0)

1 (12.5)

1 (12.5)

0 (0)

Risperidone

(n = 462)

39 (8.4)

0 (0)

26 (66.7)

2 (5.1)

7 (17.9)

4 (10.3)

Olanzapine

(n = 304)

32 (10.5)

2 (6.3)

20 (62.5)

1 (3.1)

6 (18.7)

3 (9.4)

  1. A aripiprazole, O olanzapine, P pimavanserin, Q quetiapine, R risperidone